Stock Price Targets and Analyst Ratings All RatingsU.S.U.K.CanadianUpgradesDowngradesInitiationsPrice Target ChangesMore Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrials Medical Miscellaneous Multi-Sector Conglomerates Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Ratings Strong Buy Buy Hold Sell Rating By Symbol By Time Added Sort Order Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsALGSAligos Therapeutics Initiated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingPatrick R.Subscribe to MarketBeat All Access for the recommendation accuracy rating$8.77+13.9% $50.00BuyASMBAssembly Biosciences Initiated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingPatrick TrucchioSubscribe to MarketBeat All Access for the recommendation accuracy rating$25.76+1.3% $50.00BuyBCAXBicara Therapeutics Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$11.47-1.5%OverweightCELUCelularity Initiated byWBB SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingSteve BrozakSubscribe to MarketBeat All Access for the recommendation accuracy rating$4.15+19.3% $6.00Speculative BuyCGONCG Oncology Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$26.13+1.7%OverweightCTBICommunity Trust Bancorp Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$56.49+2.6% $66.00OverweightCURICuriosityStream Initiated byCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy rating$4.21+4.5% $7.00BuyDAWNDay One Biopharmaceuticals Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$6.81+0.9%Overweight ➝ OverweightDUOLDuolingo Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingYgal Arounian$369.19+12.9% $400.00BuyFBRXForte Biosciences Initiated byGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingYatin Suneja$11.91+2.9% $75.00Buy Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. JANXJanux Therapeutics Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$25.53+1.7%OverweightLDIloanDepot Initiated byBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.88-4.8%NeutralLILi Auto Initiated byBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy rating$24.05-0.6%Outperform ➝ UnderperformLILi Auto Initiated byBNP Paribas ExaneSubscribe to MarketBeat All Access for the recommendation accuracy rating$24.05-0.6% $18.00UnderperformLITELumentum Initiated byKGI SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy rating$118.98+2.7%OutperformLYVLive Nation Entertainment Initiated byMoffett NathansonSubscribe to MarketBeat All Access for the recommendation accuracy ratingRobert Fishman$162.24+0.8% $195.00BuyMHMcGraw Hill Initiated byWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingStephen Sheldon$14.49+8.5%OutperformMHMcGraw Hill Initiated byBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating$14.49+8.5% $19.00BuyMHMcGraw Hill Initiated byBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingJeffrey Silber$14.49+8.5% $24.00OutperformMHMcGraw Hill Initiated byMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingToni Kaplan$14.49+8.5% $20.00OverweightMHMcGraw Hill Initiated byUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingJoshua Chan$14.49+8.5% $15.00NeutralMHMcGraw Hill Initiated byDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingFaiza Alwy$14.49+8.5% $18.00BuyMHMcGraw Hill Initiated byThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingGeorge Tong$14.49+8.5% $27.00BuyMHMcGraw Hill Initiated byStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingShlomo RosenbaumSubscribe to MarketBeat All Access for the recommendation accuracy rating$14.49+8.5% $19.00BuyMHMcGraw Hill Initiated byRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingJeffrey MeulerSubscribe to MarketBeat All Access for the recommendation accuracy rating$14.49+8.5% $21.00OutperformMHMcGraw Hill Initiated byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingDavid KarnovskySubscribe to MarketBeat All Access for the recommendation accuracy rating$14.49+8.5% $21.00OverweightMHMcGraw Hill Initiated byRothschild & Co RedburnSubscribe to MarketBeat All Access for the recommendation accuracy rating$14.49+8.5% $28.60BuyMHMcGraw Hill Initiated byMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingSteve Koenig$14.49+8.5% $19.00OutperformRALRalliant Initiated byRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy rating$43.27-0.5%Sector PerformRDDTReddit Initiated byArgusSubscribe to MarketBeat All Access for the recommendation accuracy rating$241.76-1.9% $250.00BuyRDWRedwire Initiated byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingRonald EpsteinSubscribe to MarketBeat All Access for the recommendation accuracy rating$9.02+0.9% $10.00UnderperformRKTRocket Companies Initiated byBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating$17.83-3.8%BuyRVMDRevolution Medicines Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$36.45+0.4%Overweight ➝ OverweightRVMDRevolution Medicines Initiated byLifesci CapitalSubscribe to MarketBeat All Access for the recommendation accuracy rating$36.45+0.4% $80.00OutperformSMMTSummit Therapeutics Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$26.29-1.5%NeutralSYNASynaptics Initiated byBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingTom O'Malley$70.12+5.0% $78.00OverweightTMOThermo Fisher Scientific Initiated byWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy rating$488.15-0.2%OutperformTNGXTango Therapeutics Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$7.22+6.6%Overweight ➝ OverweightURGNUrogen Pharma Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$19.40-1.6%OverweightVNOMViper Energy Initiated byMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingDevin McDermott$37.24-1.5% $46.00OverweightHe Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.See his full breakdown of the seven stocks to own nowXPEVXPeng Initiated byBNP Paribas ExaneSubscribe to MarketBeat All Access for the recommendation accuracy rating$19.91+1.1% $19.00NeutralXPEVXPeng Initiated byBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy rating$19.91+1.1%NeutralXRXXerox Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingAsiya MerchantSubscribe to MarketBeat All Access for the recommendation accuracy rating$3.86-4.0% $4.50NeutralAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 05:43 AM ET. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access